These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8104809)

  • 1. The effects of alpha 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats.
    Riekkinen P; Lammintausta R; Ekonsalo T; Sirviö J
    Eur J Pharmacol; 1993 Jul; 238(2-3):263-72. PubMed ID: 8104809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of the alpha 2-adrenergic antinociception from sedation following microinjection of medetomidine into the locus coeruleus in rats.
    Pertovaara A; Hämäläinen MM; Kauppila T; Mecke E; Carlson S
    Pain; 1994 May; 57(2):207-215. PubMed ID: 7916451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and suppression of immediate-early genes in the rat brain by a selective alpha-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation.
    Pertovaara A; Bravo R; Herdegen T
    Neuroscience; 1993 May; 54(1):117-26. PubMed ID: 8100045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
    Rabin BC; Guo TZ; Gregg K; Maze M
    Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of medetomidine, an alpha 2-adrenoceptor agonist, in various pain tests.
    Pertovaara A; Kauppila T; Tukeva T
    Eur J Pharmacol; 1990 Apr; 179(3):323-8. PubMed ID: 1973106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of alpha 2-adrenoceptors of the medullary lateral reticular nucleus in spinal antinociception in rats.
    Mansikka H; Pertovaara A
    Brain Res Bull; 1995; 37(6):633-8. PubMed ID: 7670889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of selective alpha 2-adrenergic agents on mustard oil-induced central hyperalgesia in rats.
    Mansikka H; Pertovaara A
    Eur J Pharmacol; 1995 Jul; 281(1):43-8. PubMed ID: 8566115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine decreases seizure threshold in a rat model of experimental generalized epilepsy.
    Mirski MA; Rossell LA; McPherson RW; Traystman RJ
    Anesthesiology; 1994 Dec; 81(6):1422-8. PubMed ID: 7992911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alpha 2-drugs and pilocarpine on the high-voltage spindle activity of young and aged control and DSP4-lesioned rats.
    Riekkinen P; Sirviö J; Jäkälä P; Riekkinen M; Lammintausta R; Riekkinen P
    Physiol Behav; 1991 Nov; 50(5):955-9. PubMed ID: 1687173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antinociceptive action of an alpha 2-adrenoceptor agonist in the spinal dorsal horn is due to a direct spinal action and not to activation of descending inhibition.
    Hämäläinen MM; Pertovaara A
    Brain Res Bull; 1995; 37(6):581-7. PubMed ID: 7670881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripherally administered alpha2-adrenoceptor agonist in the modulation of chronic allodynia induced by spinal nerve ligation in the rat.
    Wei H; Pertovaara A
    Anesth Analg; 1997 Nov; 85(5):1122-7. PubMed ID: 9356112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception.
    Pertovaara A; Kauppila T; Jyväsjärvi E; Kalso E
    Neuroscience; 1991; 44(3):705-14. PubMed ID: 1684411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats.
    Correa-Sales C; Rabin BC; Maze M
    Anesthesiology; 1992 Jun; 76(6):948-52. PubMed ID: 1350889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine.
    Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of medetomidine, an alpha-2 adrenoceptor agonist, and atipamezole, an alpha-2 antagonist, on spatial memory performance in adult and aged rats.
    Carlson S; Tanila H; Rämä P; Mecke E; Pertovaara A
    Behav Neural Biol; 1992 Sep; 58(2):113-9. PubMed ID: 1360798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of two intraventricularly injected alpha 2 agonists, ST-91 and dexmedetomidine, on electroencephalogram, feeding, and electromyogram.
    Dowlatshahi P; Yaksh TL
    Anesth Analg; 1997 Jan; 84(1):133-8. PubMed ID: 8989014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
    Honoré P; Chapman V; Buritova J; Besson JM
    J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 2-adrenoceptor-mediated inhibition of gastric acid secretion by medetomidine is efficiently antagonized by atipamezole in rats.
    Savola M; Savola JM; Puurunen J
    Arch Int Pharmacodyn Ther; 1989; 301():267-76. PubMed ID: 2576195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between the alpha 2-noradrenergic and muscarinic systems in the regulation of neocortical high voltage spindles.
    Riekkinen P; Sirviö J; Jäkälä P; Lammintausta R; Riekkinen P
    Brain Res Bull; 1990 Jul; 25(1):147-9. PubMed ID: 1976422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
    Haapalinna A; Leino T; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.